Trials running at IQRAA as a study site, with national and international sponsors and collaborators.
A multicentre, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase inhibitor BI 690517 in combination with empagliflozin in patients with chronic kidney disease
- Collaborator: Oxford University, UK
- Site Principal Investigator: Dr. Aravind Krishnakumar
Intermittent PARP Inhibitor Regimen in Ovarian Cancer (IPIROC#03): A Master Protocol of Multicentric Academic Trial
- Sponsor: Kolkata Gynecological Oncology Trials and Translational Research Group (KolGO Trg)
- Site Principal Investigator: Dr. Deepak Bose
- Site Co-Principal Investigators: Dr. Shoufeej P. M., Dr. Vajid N. V.
Bioavailability of Formulated Turmeric Milk
Investigators
- Dr. Anees K., Senior Scientist, ICAR-IISR, Calicut
- Dr. Feroz Aziz, Consultant Nephrologist, IQRAA
- Dr. Vajid N. V., Head – R&D, ICRD, IQRAA
- Ms. Fida Jabir, Chief Dietitian, IQRAA